Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | Rituximab | Case report

Pegfilgrastim

Cerebrospinal fluid pleocytosis: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Smith C, et al. A CASE SERIES OF CSF PLEOCYTOSIS IN PEDIATRIC LEUKEMIA AND LYMPHOMA PATIENTS. Pediatric Blood and Cancer 69 (Suppl. 2): S173 (plus poster) abstr. 483, Jun 2022. Available from: URL: http://doi.org/10.1002/pbc.29735 [abstract] Smith C, et al. A CASE SERIES OF CSF PLEOCYTOSIS IN PEDIATRIC LEUKEMIA AND LYMPHOMA PATIENTS. Pediatric Blood and Cancer 69 (Suppl. 2): S173 (plus poster) abstr. 483, Jun 2022. Available from: URL: http://​doi.​org/​10.​1002/​pbc.​29735 [abstract]
Metadata
Title
Pegfilgrastim
Cerebrospinal fluid pleocytosis: 3 case reports
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-18073-8

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Iopromide

Case report

Milrinone

Case report

Cefuroxime

Case report

Apixaban